| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
CYTK
Cytokinetics
|
Jun 16, 2026 | BUY |
Strong Buy
+9.9% avg upside
36 analysts
|
$99.00
26.72% Upside
|
+5.0% |
|
PTCT
PTC Therapeutics
|
Jun 10, 2026 | BUY |
Strong Buy
-1.0% avg upside
29 analysts
|
$108.00
37.46% Upside
|
+7.1% |
|
BBIO
BridgeBio Pharma
|
Jun 01, 2026 | HOLD |
Strong Buy
+36.6% avg upside
34 analysts
|
$82.00
21.69% Upside
|
+3.1% |
|
IONS
Ionis Pharmaceuticals
|
May 20, 2026 | BUY |
Strong Buy
+13.0% avg upside
43 analysts
|
$90.00
21.15% Upside
|
-2.4% |
|
BMRN
BioMarin Pharmaceutical
|
May 20, 2026 | BUY |
Strong Buy
+71.7% avg upside
52 analysts
|
$80.00
45.41% Upside
|
+9.6% |
|
ALNY
Alnylam Pharma
|
May 19, 2026 | BUY |
Strong Buy
+22.4% avg upside
51 analysts
|
$380.00
34.45% Upside
|
-3.9% |
|
ASND
Ascendis Pharma
|
May 15, 2026 | BUY |
Strong Buy
+16.5% avg upside
24 analysts
|
$355.00
53.51% Upside
|
-7.2% |
|
TGTX
TG Therapeutics
|
Nov 03, 2025 | BUY |
Strong Buy
-32.7% avg upside
19 analysts
|
$49.00
4.90% Downside
|
+50.0% |
|
PLRX
Pliant Therapeutics
|
Oct 10, 2025 | SELL |
Buy
+1806.3% avg upside
21 analysts
|
— | +16.3% |
|
BEAM
Beam Therapeutics
|
Jun 25, 2025 | BUY |
Strong Buy
+57.5% avg upside
25 analysts
|
$48.00
47.83% Upside
|
+75.4% |
|
KYMR
Kymera Therapeutics
|
Jun 02, 2025 | BUY |
Strong Buy
+9.5% avg upside
36 analysts
|
$64.00
28.90% Downside
|
+65.3% |
|
RCKT
Rocket Pharmaceuticals
|
May 28, 2025 | HOLD |
Buy
+418.9% avg upside
29 analysts
|
$7.00
121.61% Upside
|
+19.4% |
|
PRME
Prime Medicine, Inc.
|
May 19, 2025 | HOLD |
Strong Buy
+215.8% avg upside
16 analysts
|
— | +102.2% |
|
NVAX
Novavax
|
May 19, 2025 | SELL |
Buy
+146.7% avg upside
20 analysts
|
$7.00
26.28% Downside
|
-15.0% |
|
CAMP
CAMP4 Therapeutics Corporation
|
May 16, 2025 | BUY |
Strong Buy
+131.0% avg upside
9 analysts
|
$18.00
334.79% Upside
|
+87.4% |
|
SEPN
Septerna, Inc.
|
May 14, 2025 | BUY |
Strong Buy
+19.4% avg upside
12 analysts
|
— | +178.7% |
|
RLAY
Relay Therapeutics
|
May 13, 2025 | BUY |
Strong Buy
+28.3% avg upside
19 analysts
|
$11.00
29.28% Downside
|
+367.1% |
|
VIR
Vir Biotechnology
|
May 07, 2025 | HOLD |
Strong Buy
+182.3% avg upside
16 analysts
|
$14.00
50.57% Upside
|
+65.2% |
|
OPK
Opko Health
|
Apr 25, 2025 | HOLD |
Buy
+377.2% avg upside
12 analysts
|
— | -12.8% |
|
GLUE
Monte Rosa Therapeutics
|
Mar 20, 2025 | BUY |
Strong Buy
+27.2% avg upside
14 analysts
|
$12.00
34.86% Downside
|
+121.4% |
|
WVE
Wave Life Sciences
|
Mar 04, 2025 | BUY |
Strong Buy
+272.2% avg upside
28 analysts
|
$21.00
253.01% Upside
|
+22.1% |
|
RVMD
Revolution Medicines
|
Feb 27, 2025 | BUY |
Strong Buy
-10.2% avg upside
32 analysts
|
$70.00
55.70% Downside
|
+161.1% |
|
ENTA
Enanta Pharmaceuticals
|
Feb 10, 2025 | SELL |
Buy
+160.1% avg upside
17 analysts
|
$5.00
60.44% Downside
|
-188.4% |
|
NRIX
Nurix Therapeutics
|
Jan 29, 2025 | BUY |
Strong Buy
+79.9% avg upside
26 analysts
|
$30.00
75.23% Upside
|
-10.5% |
|
BMEA
Biomea Fusion
|
Dec 17, 2024 | HOLD |
Strong Buy
+1020.0% avg upside
15 analysts
|
$11.00
816.67% Upside
|
-70.9% |
|
CCCC
C4 Therapeutics
|
Feb 23, 2024 | HOLD |
Strong Buy
+354.5% avg upside
19 analysts
|
$7.00
78.59% Upside
|
-66.5% |
|
RXRX
Recursion Pharmaceuticals
|
Nov 13, 2023 | HOLD |
Buy
+155.0% avg upside
12 analysts
|
$10.00
221.47% Upside
|
+25.6% |
|
IPSC
Century Therapeutics
|
Aug 28, 2023 | HOLD |
Strong Buy
+136.7% avg upside
11 analysts
|
$5.00
122.29% Upside
|
-34.3% |
|
LYEL
Lyell Immunopharma
|
Aug 28, 2023 | HOLD |
Buy
+99.4% avg upside
10 analysts
|
$5.00
59.98% Downside
|
-34.1% |
|
AVIR
Atea Pharmaceuticals
|
Aug 10, 2023 | SELL |
Buy
+50.1% avg upside
6 analysts
|
— | +0.6% |
|
AUTL
Autolus Therapeutics
|
May 05, 2023 | HOLD |
Strong Buy
+597.7% avg upside
16 analysts
|
$5.00
226.85% Upside
|
+121.7% |
|
SRZN
Surrozen
|
Nov 29, 2022 | SELL |
Buy
+49.1% avg upside
7 analysts
|
— | +41.4% |
|
KPTI
Karyopharm Therapeutics
|
Nov 04, 2022 | HOLD |
Strong Buy
+139.5% avg upside
18 analysts
|
$5.00
46.91% Downside
|
-81.2% |
|
IRWD
Ironwood Pharma
|
May 05, 2022 | HOLD |
Hold
+236.0% avg upside
23 analysts
|
$13.00
269.39% Upside
|
-12.8% |
|
ALGS
Aligos Therapeutics
|
May 05, 2022 | HOLD |
Strong Buy
+765.6% avg upside
11 analysts
|
$5.00
6.54% Downside
|
+12.7% |
|
BDTX
Black Diamond Therapeutics
|
Mar 29, 2022 | BUY |
Strong Buy
+980.8% avg upside
12 analysts
|
$7.00
319.18% Upside
|
-33.8% |
|
AKBA
Akebia Therapeutics
|
Mar 04, 2022 | SELL |
Strong Buy
+864.1% avg upside
16 analysts
|
— | +60.1% |
|
DTIL
Precision BioSciences
|
Nov 11, 2021 | HOLD |
Strong Buy
+261.6% avg upside
12 analysts
|
$11.00
69.23% Upside
|
-85.7% |
|
OMER
Omeros
|
Oct 08, 2021 | SELL |
Buy
+113.6% avg upside
14 analysts
|
— | +41.5% |
|
OBSEF
ObsEva
|
Nov 09, 2020 | SELL |
Buy
+10799900.0% avg upside
8 analysts
|
— | · |
|
URGN
Urogen Pharma
|
Sep 21, 2020 | HOLD |
Strong Buy
+15.4% avg upside
16 analysts
|
$26.00
20.84% Downside
|
-19.9% |
|
PGEN
Precigen
|
Feb 07, 2020 | HOLD |
Buy
+412.5% avg upside
11 analysts
|
— | -20.6% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.